why choose us

First received: March 06, 2024

Clinical Trial: Effect of Vericiguat on Acute Coronary Syndrome( ACS?Patients With Ejection Fraction <45%

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Acute Coronary Syndrome

Study Type: OBSERVATIONAL


Official Title: Vericiguat in Patients With Acute Coronary Syndrome and Reduced Ejection Fraction: The EVE-ACSrEF Study

Brief Summary: Investigators evaluate whether differences exsit in acute coronary syndrome?ACS? patients with ejection <45% between participants who take vericiguat regularly and those who donot.

Read more